ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
2,1,Bundle branch block left,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
2,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
3,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3,2,Coronary artery stenosis,Coronary artery disorders NEC,Coronary artery disorders,Card,N
3,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
4,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
5,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
5,2,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
5,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
6,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
6,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
6,3,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
7,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
7,2,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
8,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
9,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
9,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
9,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
9,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
9,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
9,6,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
10,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
11,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
12,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
12,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
12,3,Penile oedema,Penile disorders NEC (excl erection and ejaculation),Penile and scrotal disorders (excl infections and inflammations),Repro,N
12,4,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
12,5,Scrotal oedema,Scrotal disorders NEC,Penile and scrotal disorders (excl infections and inflammations),Repro,N
12,6,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
13,1,Conjunctival haemorrhage,Conjunctival and corneal bleeding and vascular disorders,Ocular haemorrhages and vascular disorders NEC,Eye,N
13,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
13,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
13,4,Retinal haemorrhage,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
13,5,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
13,6,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
14,1,Non-small cell lung cancer,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,Y
15,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
16,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
17,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
17,2,Bundle branch block left,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
17,3,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
17,4,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
18,1,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
18,2,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
18,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
19,1,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
19,2,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
20,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
20,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
20,3,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
21,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
21,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
21,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
21,4,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
21,5,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
22,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
22,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
22,3,Coronary artery stenosis,Coronary artery disorders NEC,Coronary artery disorders,Card,N
22,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
22,5,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
22,6,Platelet count abnormal,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
22,7,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
23,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
24,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
25,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
25,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
25,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
25,4,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
25,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
25,6,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
26,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
26,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
26,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
26,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
26,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
27,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
28,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
28,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
28,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
28,4,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
28,5,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
28,6,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
28,7,Pleuritic pain,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
28,8,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
29,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
29,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
30,1,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
30,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
31,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
31,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
31,3,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
32,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
32,2,Scrotal oedema,Scrotal disorders NEC,Penile and scrotal disorders (excl infections and inflammations),Repro,N
32,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
33,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
34,1,Blast cell proliferation,Myeloproliferative disorders (excl leukaemias),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
34,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
35,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
35,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
36,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
37,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
37,2,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
38,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
38,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
39,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
39,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
40,1,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
40,2,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
41,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
41,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
42,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
42,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
42,3,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
43,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
44,1,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
44,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
44,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
45,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
46,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
47,1,Hypoalbuminaemia,Protein metabolism disorders NEC,Protein and amino acid metabolism disorders NEC,Metab,N
47,2,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
48,1,Cardiomegaly,Myocardial disorders NEC,Myocardial disorders,Card,N
48,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
48,3,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
49,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
49,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
49,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
49,4,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
50,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
51,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
51,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
51,3,Exercise tolerance decreased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
51,4,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
51,5,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
52,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
52,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
52,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
52,4,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
53,1,Congenital anomaly,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
53,2,Encephalocele,Central nervous system disorders congenital NEC,Neurological disorders congenital,Cong,N
53,3,Foetal malformation,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
54,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
55,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
55,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
55,3,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
56,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
56,2,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
57,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
58,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
59,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
60,1,Erythema nodosum,Panniculitides,Skin and subcutaneous tissue disorders NEC,Skin,N
61,1,Haemothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
61,2,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
61,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
62,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
63,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
63,2,Lymphocytosis,Leukocytoses NEC,White blood cell disorders,Blood,N
64,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
65,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
66,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
67,1,Oesophageal carcinoma,Oesophageal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
68,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
68,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
68,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
68,4,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
68,5,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
68,6,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
69,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
70,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
70,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
70,3,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
71,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
71,2,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
71,3,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
72,1,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
73,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
73,2,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
74,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
74,2,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
74,3,Diarrhoea haemorrhagic,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
75,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
75,2,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
75,3,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
76,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
76,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
76,3,Lung infiltration,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
76,4,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
77,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
77,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
77,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
78,1,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
78,2,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
79,1,Cardiogenic shock,Heart failures NEC,Heart failures,Card,N
79,2,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,Y
79,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
79,4,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
79,5,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
80,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
80,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
80,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
80,4,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
80,5,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
80,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
80,7,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
81,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
81,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
81,3,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
81,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
82,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
83,1,Open angle glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
84,1,Hyperkeratosis,Hyperkeratoses,Cornification and dystrophic skin disorders,Skin,N
84,2,Palmoplantar keratoderma,Hyperkeratoses,Cornification and dystrophic skin disorders,Skin,N
85,1,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
86,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
87,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
88,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
89,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
90,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
90,2,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
91,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
92,1,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
92,2,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
93,1,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
94,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
94,2,Pulmonary mass,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
94,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
95,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
95,2,Iron deficiency anaemia,Anaemia deficiencies,Anaemias nonhaemolytic and marrow depression,Blood,N
96,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
97,1,Breast swelling,Breast signs and symptoms,Breast disorders,Repro,N
97,2,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
97,3,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
97,4,Menstruation delayed,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
97,5,Oestradiol increased,Reproductive hormone analyses,Endocrine investigations (incl sex hormones),Inv,N
98,1,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
99,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
100,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
101,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
102,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
103,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
104,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
105,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
105,2,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
106,1,Ovarian cancer,Ovarian neoplasms malignant (excl germ cell),Reproductive neoplasms female malignant and unspecified,Neopl,Y
107,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
107,2,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
107,3,Iron deficiency anaemia,Anaemia deficiencies,Anaemias nonhaemolytic and marrow depression,Blood,N
107,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
107,5,Migraine,Migraine headaches,Headaches,Nerv,N
107,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
107,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
108,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
108,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
108,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
108,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
108,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
108,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
108,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
109,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
109,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
109,3,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
109,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
110,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
110,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
110,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
110,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
111,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
112,1,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
113,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
113,2,Iron deficiency anaemia,Anaemia deficiencies,Anaemias nonhaemolytic and marrow depression,Blood,N
113,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
113,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
114,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
115,1,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
115,2,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
115,3,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
116,1,Myelofibrosis,Myeloproliferative disorders (excl leukaemias),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
117,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
118,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
119,1,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
119,2,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
120,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
121,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
122,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
123,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
123,2,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
123,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
124,1,Visual field defect,Visual field disorders,Vision disorders,Eye,N
125,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
125,2,HIV test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
125,3,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
126,1,Pericardial disease,Pericardial disorders NEC,Pericardial disorders,Card,N
126,2,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
127,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
128,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
129,1,Bone marrow transplant,Haematological therapeutic procedures NEC,Haematological and lymphoid tissue therapeutic procedures,Surg,N
130,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
131,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
132,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
133,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
134,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
135,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
136,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
137,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
137,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
138,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
138,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
139,1,Nipple pain,Breast signs and symptoms,Breast disorders,Repro,N
139,2,Nipple swelling,Breast signs and symptoms,Breast disorders,Repro,N
140,1,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
141,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
141,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
142,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
142,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
143,1,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
144,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
145,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
146,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
146,2,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
146,3,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
147,1,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
147,2,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
148,1,Asbestosis,Chest and respiratory tract injuries NEC,Injuries NEC,Inj&P,N
148,2,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
148,3,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
149,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
149,2,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
150,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
151,1,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
151,2,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
152,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
153,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
154,1,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
154,2,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
155,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
156,1,Pulmonary arterial hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
156,2,Right ventricular failure,Right ventricular failures,Heart failures,Card,N
157,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
157,2,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
157,3,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
157,4,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
157,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
157,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
158,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
159,1,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
159,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
160,1,Empyema,Infections NEC,Infections - pathogen unspecified,Infec,N
160,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
160,3,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
160,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
161,1,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
161,2,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
162,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
163,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
163,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
164,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
164,2,Headache,Headaches NEC,Headaches,Nerv,N
165,1,Acarodermatitis,Ectoparasitic infestations,Ectoparasitic disorders,Infec,N
166,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
166,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
166,3,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
167,1,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
167,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
167,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
167,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
167,5,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
168,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
168,2,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
168,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
169,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
169,2,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
169,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
169,4,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
170,1,Enterocolitis haemorrhagic,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
170,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
171,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
171,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
172,1,Coronary artery disease,Coronary artery disorders NEC,Coronary artery disorders,Card,N
172,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
172,3,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
173,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
174,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
175,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
175,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
176,1,Foaming at mouth,General signs and symptoms NEC,General system disorders NEC,Genrl,N
176,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
176,3,Screaming,General signs and symptoms NEC,General system disorders NEC,Genrl,N
176,4,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
176,5,Tongue disorder,Tongue disorders,Tongue conditions,Gastr,N
177,1,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
177,2,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
178,1,Colon cancer metastatic,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,Y
179,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
180,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
180,2,Glomerulonephritis,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
180,3,Headache,Headaches NEC,Headaches,Nerv,N
180,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
180,5,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
180,6,Renal vasculitis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
181,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
182,1,Bundle branch block left,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
182,2,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
183,1,Myelocytosis,Leukocytoses NEC,White blood cell disorders,Blood,N
184,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
185,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
186,1,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
187,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
187,2,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
187,3,Musculoskeletal pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
187,4,Peripheral artery stenosis,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
187,5,Rheumatoid factor increased,Autoimmunity analyses,Immunology and allergy investigations,Inv,N
188,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
189,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
189,2,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
189,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
189,4,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
189,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
189,6,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
189,7,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
190,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
190,2,Ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
191,1,Atypical pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
191,2,Periorbital cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
191,3,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
192,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
192,2,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
193,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
193,2,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
193,3,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
194,1,Allogenic stem cell transplantation,Blood and blood product treatment,Haematological and lymphoid tissue therapeutic procedures,Surg,N
194,2,Chronic myeloid leukaemia,Leukaemias chronic myeloid,Leukaemias,Neopl,N
194,3,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
195,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
195,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
196,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
196,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
196,3,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
196,4,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
196,5,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
196,6,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
196,7,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
196,8,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
196,9,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
196,10,Hypomania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
196,11,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
196,12,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
196,13,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
196,14,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
196,15,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
196,16,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
196,17,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
196,18,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
196,19,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
197,1,Amylase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
198,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
199,1,Macular hole,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
200,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
200,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
201,1,Transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,Y
202,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
203,1,Blast crisis in myelogenous leukaemia,Leukaemias myeloid NEC,Leukaemias,Neopl,N
203,2,Chronic myeloid leukaemia,Leukaemias chronic myeloid,Leukaemias,Neopl,N
203,3,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
203,4,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
203,5,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
204,1,Blast crisis in myelogenous leukaemia,Leukaemias myeloid NEC,Leukaemias,Neopl,N
204,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
204,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
205,1,Chronic graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
205,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
206,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
206,2,Pneumonia cytomegaloviral,Cytomegaloviral infections,Viral infectious disorders,Infec,N
206,3,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
207,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
207,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
207,3,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
208,1,Acute graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
208,2,Chronic graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
208,3,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
208,4,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
209,1,Transposition of the great vessels,Great vessel disorders congenital,Cardiac and vascular disorders congenital,Cong,N
210,1,Gastric antral vascular ectasia,Gastrointestinal vascular malformations,Gastrointestinal vascular conditions,Gastr,N
211,1,Acute lymphocytic leukaemia recurrent,Leukaemias acute lymphocytic,Leukaemias,Neopl,N
212,1,Acute lymphocytic leukaemia recurrent,Leukaemias acute lymphocytic,Leukaemias,Neopl,N
212,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
213,1,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
214,1,Cardiac failure acute,Heart failures NEC,Heart failures,Card,N
214,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
214,3,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
215,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
215,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
215,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
216,1,Abortion,Abortions not specified as induced or spontaneous,Abortions and stillbirth,Preg,N
216,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
216,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
217,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
217,2,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
217,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
218,1,Chylothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
219,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
219,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
219,3,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
220,1,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
221,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
221,2,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
221,3,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
222,1,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
222,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
222,3,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
222,4,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
222,5,Orthopnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
222,6,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
222,7,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
222,8,Respiratory tract congestion,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
222,9,Sputum discoloured,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
222,10,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
223,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
224,1,Acute lymphocytic leukaemia,Leukaemias acute lymphocytic,Leukaemias,Neopl,N
224,2,Acute lymphocytic leukaemia recurrent,Leukaemias acute lymphocytic,Leukaemias,Neopl,N
224,3,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
224,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
225,1,Glioma,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
226,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
226,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
226,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
226,4,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
226,5,Peripheral arterial occlusive disease,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
226,6,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
226,7,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
226,8,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
227,1,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
228,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
228,2,Pulmonary arterial hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
229,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
229,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
229,3,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
229,4,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
230,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
230,2,Pleurodesis,Pleural therapeutic procedures,Respiratory tract therapeutic procedures,Surg,N
231,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
231,2,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
231,3,Nephrotic syndrome,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
231,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
231,5,Urine protein/creatinine ratio increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
232,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
233,1,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
234,1,Angiopathy,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
234,2,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
234,3,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,Y
234,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
235,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
236,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
237,1,Back disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
238,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
238,2,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
238,3,Blood phosphorus decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
238,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
239,1,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
240,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
240,2,Pulmonary artery dilatation,Vascular pulmonary disorders NEC,Pulmonary vascular disorders,Resp,N
241,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
242,1,Hypervolaemia,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
242,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
243,1,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
243,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
243,3,Renal tubular disorder,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
244,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
245,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
246,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
247,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
248,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
248,2,Eye haemorrhage,Ocular bleeding and vascular disorders NEC,Ocular haemorrhages and vascular disorders NEC,Eye,N
248,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
249,1,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
250,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
250,2,Pulmonary arterial hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
251,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
252,1,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
253,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
253,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
253,3,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
253,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
254,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
255,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
256,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
257,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
258,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
258,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
258,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
259,1,Perineal infection,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
260,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
260,2,Orbital haemorrhage,Ocular bleeding and vascular disorders NEC,Ocular haemorrhages and vascular disorders NEC,Eye,N
261,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
261,2,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
261,3,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
261,4,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
261,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
261,6,Scrotal swelling,Scrotal disorders NEC,Penile and scrotal disorders (excl infections and inflammations),Repro,N
262,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
262,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
262,3,Social avoidant behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
262,4,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
263,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
263,2,Peripheral vascular disorder,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
264,1,Lower limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
264,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
265,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
265,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
266,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
266,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
266,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
266,4,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
266,5,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
267,1,Epicondylitis,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
268,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
269,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
270,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
270,2,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
271,1,Gastrointestinal toxicity,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
271,2,Graft versus host disease in liver,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
271,3,Graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
271,4,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
271,5,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
271,6,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
272,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
273,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
273,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
273,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
274,1,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
274,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
274,3,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
274,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
274,5,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
274,6,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
275,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
275,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
275,3,Cytogenetic analysis abnormal,Chromosome analyses,Cytogenetic investigations and genetic analyses,Inv,N
275,4,Dysstasia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
275,5,Ehlers-Danlos syndrome,Connective tissue disorders congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
275,6,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
275,7,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
275,8,Ventricular tachycardia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
276,1,Bundle branch block right,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
276,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
276,3,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
276,4,Prescribed underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
276,5,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
276,6,Ventricular extrasystoles,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
277,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
277,2,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
278,1,Choking,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
278,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
279,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
279,2,Mitral valve incompetence,Mitral valvular disorders,Cardiac valve disorders,Card,N
279,3,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
280,1,Cytogenetic analysis abnormal,Chromosome analyses,Cytogenetic investigations and genetic analyses,Inv,N
280,2,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
280,3,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
280,4,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
281,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
281,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
282,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
282,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
283,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
284,1,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
284,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
284,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
284,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
285,1,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
285,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
285,3,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
285,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
285,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
286,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
287,1,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
287,2,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
287,3,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
288,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
289,1,Affective disorder,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
289,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
289,3,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
289,4,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
289,5,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
289,6,Dysmenorrhoea,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
289,7,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
289,8,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
289,9,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
289,10,Miliaria,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
289,11,Muscle discomfort,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
289,12,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
289,13,Temperature intolerance,Feelings and sensations NEC,General system disorders NEC,Genrl,N
289,14,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
290,1,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
291,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
291,2,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
292,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
293,1,Coronary artery stenosis,Coronary artery disorders NEC,Coronary artery disorders,Card,N
293,2,Cytogenetic analysis abnormal,Chromosome analyses,Cytogenetic investigations and genetic analyses,Inv,N
293,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
293,4,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
293,5,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
293,6,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
293,7,Gene mutation identification test positive,Gene analyses,Cytogenetic investigations and genetic analyses,Inv,N
293,8,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
293,9,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
294,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
295,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
296,1,Teeth brittle,Dental disorders NEC,Dental and gingival conditions,Gastr,N
297,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
297,2,Arteriosclerosis coronary artery,Coronary artery disorders NEC,Coronary artery disorders,Card,N
297,3,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
297,4,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
297,5,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
297,6,Cataract subcapsular,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
297,7,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
297,8,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
297,9,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
297,10,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
297,11,Headache,Headaches NEC,Headaches,Nerv,N
297,12,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
297,13,Migraine,Migraine headaches,Headaches,Nerv,N
297,14,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
297,15,Premature menopause,Menopausal effects NEC,Menopause related conditions,Repro,N
297,16,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
298,1,Concomitant disease aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
298,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
298,3,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
299,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
300,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
301,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
302,1,Haematotoxicity,Haematological disorders,Haematological disorders NEC,Blood,N
302,2,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
303,1,Acute lymphocytic leukaemia,Leukaemias acute lymphocytic,Leukaemias,Neopl,N
303,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
303,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
304,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
304,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
304,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
305,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
305,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
305,3,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
305,4,Chronic myeloid leukaemia recurrent,Leukaemias chronic myeloid,Leukaemias,Neopl,N
305,5,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
305,6,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
305,7,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
305,8,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
305,9,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
305,10,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
305,11,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
305,12,Myalgia,Muscle pains,Muscle disorders,Musc,N
305,13,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
305,14,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
305,15,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
305,16,Shift to the left,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
305,17,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
305,18,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
305,19,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
306,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
306,2,Haematotoxicity,Haematological disorders,Haematological disorders NEC,Blood,N
306,3,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
307,1,Cardiotoxicity,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
307,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
308,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
309,1,Blood pH increased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
309,2,Cytogenetic analysis abnormal,Chromosome analyses,Cytogenetic investigations and genetic analyses,Inv,N
309,3,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
309,4,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
309,5,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
309,6,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
310,1,Chronic myeloid leukaemia,Leukaemias chronic myeloid,Leukaemias,Neopl,N
310,2,Cytogenetic analysis abnormal,Chromosome analyses,Cytogenetic investigations and genetic analyses,Inv,N
310,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
310,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
311,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
311,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
311,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
311,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
311,5,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
311,6,Myalgia,Muscle pains,Muscle disorders,Musc,N
312,1,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
312,2,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
312,3,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
312,4,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
312,5,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
312,6,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
313,1,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
313,2,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
313,3,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
314,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
315,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
315,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
315,3,Hypercholesterolaemia,Elevated cholesterol,Lipid metabolism disorders,Metab,N
315,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
315,5,Renal artery stenosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
315,6,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
316,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
316,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
316,3,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
316,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
316,5,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
316,6,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
317,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
317,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
317,3,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
317,4,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
317,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
317,6,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
317,7,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
318,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
318,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
318,3,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
318,4,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
318,5,Obesity,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
318,6,Philadelphia chromosome positive,Chromosome analyses,Cytogenetic investigations and genetic analyses,Inv,N
319,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
319,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
319,3,Headache,Headaches NEC,Headaches,Nerv,N
319,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
319,5,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
319,6,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
320,1,Clonal evolution,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
320,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
320,3,Loss of therapeutic response,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
320,4,Peripheral vascular disorder,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
320,5,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
321,1,Clonal evolution,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
321,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
321,3,Loss of therapeutic response,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
321,4,Peripheral vascular disorder,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
321,5,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
322,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
323,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
323,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
323,3,Philadelphia chromosome positive,Chromosome analyses,Cytogenetic investigations and genetic analyses,Inv,N
323,4,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
324,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
324,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
325,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
326,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
326,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
326,3,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
327,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
327,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
327,3,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
327,4,Mouth haemorrhage,Oral soft tissue haemorrhages,Oral soft tissue conditions,Gastr,N
328,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
328,2,Migraine,Migraine headaches,Headaches,Nerv,N
328,3,Raynaud's phenomenon,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
329,1,Aphthous ulcer,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
329,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
329,3,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
329,4,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
330,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
330,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
330,3,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
330,4,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
331,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
331,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
332,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
332,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
333,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
333,2,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
333,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
333,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
333,5,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
333,6,Musculoskeletal pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
333,7,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
333,8,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
333,9,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
333,10,Pulmonary arterial pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
334,1,Large granular lymphocytosis,Leukaemias chronic T-cell,Leukaemias,Neopl,N
335,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
335,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
336,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
336,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
336,3,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
336,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
337,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
337,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
338,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
338,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
339,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
339,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
339,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
339,4,Vascular insufficiency,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
340,1,Acute lymphocytic leukaemia,Leukaemias acute lymphocytic,Leukaemias,Neopl,N
340,2,Acute lymphocytic leukaemia recurrent,Leukaemias acute lymphocytic,Leukaemias,Neopl,N
340,3,Bone marrow disorder,Haematological disorders,Haematological disorders NEC,Blood,N
340,4,Bone neoplasm,Bone neoplasms unspecified malignancy,Skeletal neoplasms malignant and unspecified,Neopl,N
340,5,Central nervous system neoplasm,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
340,6,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
340,7,Full blood count decreased,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
340,8,Loss of CAR T-cell persistence,Site specific procedural complications NEC,Procedural related injuries and complications NEC,Inj&P,N
340,9,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
341,1,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
341,2,Cytomegalovirus enteritis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
342,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
342,2,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
342,3,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
343,1,Cardiac dysfunction,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
343,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
343,3,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
344,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
344,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
344,3,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
345,1,Cytogenetic abnormality,Chromosomal abnormalities NEC,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
345,2,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
346,1,Philadelphia chromosome positive,Chromosome analyses,Cytogenetic investigations and genetic analyses,Inv,N
346,2,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
347,1,Chronic myeloid leukaemia,Leukaemias chronic myeloid,Leukaemias,Neopl,N
347,2,Cytogenetic analysis abnormal,Chromosome analyses,Cytogenetic investigations and genetic analyses,Inv,N
347,3,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
347,4,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
347,5,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
347,6,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
348,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
348,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
349,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
349,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
350,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
350,2,Headache,Headaches NEC,Headaches,Nerv,N
351,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
351,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
351,3,Philadelphia chromosome positive,Chromosome analyses,Cytogenetic investigations and genetic analyses,Inv,N
351,4,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
351,5,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
351,6,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
352,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
353,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
353,2,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
354,1,Traumatic lung injury,Chest and respiratory tract injuries NEC,Injuries NEC,Inj&P,N
355,1,Polymerase chain reaction,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
356,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
356,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
356,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
356,4,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
356,5,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
356,6,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
356,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
357,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
358,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
358,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
358,3,Gene mutation,Gene mutations and other alterations NEC,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
359,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
359,2,Gene mutation,Gene mutations and other alterations NEC,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
360,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
360,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
360,3,Full blood count normal,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
360,4,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
361,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
362,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
362,2,Peripheral arterial occlusive disease,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
363,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
364,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
365,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
365,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
365,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
365,4,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
366,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
366,2,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
366,3,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
367,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
367,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
367,3,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
367,4,Polymerase chain reaction positive,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
367,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
368,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
368,2,Headache,Headaches NEC,Headaches,Nerv,N
368,3,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
368,4,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
369,1,Acute lymphocytic leukaemia,Leukaemias acute lymphocytic,Leukaemias,Neopl,N
369,2,Cerebral toxoplasmosis,Toxoplasma infections,Protozoal infectious disorders,Infec,N
369,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
369,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
369,5,Recurrent cancer,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
369,6,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
369,7,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
370,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
370,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
370,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
370,4,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
371,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
371,2,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
371,3,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
372,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
373,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
374,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
374,2,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
374,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
374,4,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
374,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
374,6,Headache,Headaches NEC,Headaches,Nerv,N
374,7,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
374,8,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
375,1,Cardiovascular disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
375,2,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
376,1,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
377,1,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
378,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
378,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
379,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
379,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
380,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
380,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
380,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
381,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
381,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
381,3,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
381,4,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
381,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
382,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
382,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
382,3,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
383,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
383,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
383,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
383,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
384,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
384,2,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
385,1,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
386,1,Cytogenetic analysis abnormal,Chromosome analyses,Cytogenetic investigations and genetic analyses,Inv,N
386,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
386,3,Gastrointestinal toxicity,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
386,4,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
386,5,Panniculitis,Panniculitides,Skin and subcutaneous tissue disorders NEC,Skin,N
386,6,Peripheral vascular disorder,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
386,7,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
386,8,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
387,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
387,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
387,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
387,4,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
388,1,Chronic myeloid leukaemia,Leukaemias chronic myeloid,Leukaemias,Neopl,N
388,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
388,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
389,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
390,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
390,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
391,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
392,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
392,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
392,3,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
392,4,Headache,Headaches NEC,Headaches,Nerv,N
392,5,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
392,6,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
392,7,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
392,8,Myalgia,Muscle pains,Muscle disorders,Musc,N
392,9,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
392,10,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
393,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
394,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
395,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
396,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
396,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
397,1,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
397,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
398,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
399,1,Full blood count abnormal,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
399,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
400,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
400,2,Muscle disorder,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
400,3,Myopathy toxic,Myopathies,Muscle disorders,Musc,N
400,4,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
401,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
402,1,Hair colour changes,Pilar disorders NEC,Skin appendage conditions,Skin,N
403,1,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
404,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
404,2,Muscle disorder,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
404,3,Myopathy toxic,Myopathies,Muscle disorders,Musc,N
405,1,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
406,1,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
407,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
408,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
408,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
408,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
409,1,Glossodynia,Tongue signs and symptoms,Tongue conditions,Gastr,N
409,2,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
410,1,Aspiration pleural cavity,Respiratory tract and thoracic histopathology procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
411,1,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
412,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
413,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
413,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
413,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
413,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
414,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
415,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
415,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
415,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
415,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
415,5,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
416,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
417,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
418,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
418,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
419,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
419,2,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
419,3,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
419,4,Polymerase chain reaction positive,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
420,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
420,2,Gastroenteritis viral,Viral infections NEC,Viral infectious disorders,Infec,N
420,3,Gastrointestinal inflammation,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
420,4,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
421,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
422,1,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
423,1,Pulmonary function test,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
424,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
424,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
424,3,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
424,4,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
424,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
424,6,Headache,Headaches NEC,Headaches,Nerv,N
424,7,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
424,8,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
424,9,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
424,10,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
425,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
426,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
426,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
426,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
427,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
427,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
427,3,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
427,4,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
427,5,Gastrointestinal motility disorder,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
427,6,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
427,7,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
428,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
428,2,Change of bowel habit,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
428,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
428,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
428,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
428,6,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
428,7,Pulmonary arterial hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
428,8,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
428,9,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
428,10,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
429,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
430,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
